Amarna Therapeutics and NorthX Biologics finalized an agreement to advance Nimvec AM510 gene therapy toward clinical trials for Type 1 Diabetes. Now in its fourth year, the MM+M Media Summit brings ...

With half a million people having already received multi-cancer early detection (MCED) screening, patients are and will continue to be asking about these blood tests during their visits, physicians ...

Beam Therapeutics Inc. (BEAM) shares ended the last trading session 5.7% higher at $21.46. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

The nine suits filed this month alleged the telecom giants have infringed on patents attributed to Headwater Research and its ...

New developments tackle two of the biggest challenges in plasma-wave acceleration: beam quality and bunch rate.

While radiation treatments designed to kill cancer cells have come a long way, scientists and doctors are always exploring ...

Molecular profiling could reduce both overtreatment and undertreatment of patients with high-intermediate risk endometrial ...

Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...

Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On July 1, ...

Beam Therapeutics Inc. (NASDAQ:BEAM) ranks among the best CRISPR stocks to buy. On June 13, Beam Therapeutics Inc.

A facility designed to treat mental health disorders among Douglas County inmates hit a major milestone Wednesday.

Beam Therapeutics faces slow pipeline progress and high R&D costs despite a $500M cash boost. Click here to read an analysis of BEAM stock now.